Interestingly, the preceding scenario is mitigated by administration of an antibody specific to PSGL-1, allowing conclusions to be made around the negative contribution of PSGL-1 to the pathogenesis of acute coronary syndrome. The gene discussed is SELPLG; the disease is acute coronary syndrome.